Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 108.41 USD 1.06% Market Closed
Market Cap: 22.1B USD
Have any thoughts about
Zimmer Biomet Holdings Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one ZBH stock under the Base Case scenario is 179.47 USD. Compared to the current market price of 108.41 USD, Zimmer Biomet Holdings Inc is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZBH Relative Value
Base Case
179.47 USD
Undervaluation 40%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.8
P/S
P/S
Price to Sales
2.8
vs History
92
vs Industry
39
Median 3Y
3.5
Median 5Y
3.6
Industry
2.4
Forward
2.8
More Details
20
P/E
P/E
Price to Earnings
20
vs History
80
vs Industry
24
Median 3Y
54.6
Median 5Y
46.3
Industry
22.9
Forward
13.2
More Details
13.7
P/OCF
P/OCF
Price to OCF
13.7
vs History
92
vs Industry
26
Median 3Y
16.6
Median 5Y
17.8
Industry
14.5
More Details
11.9
P/FCFE
P/FCFE
Price to FCFE
11.9
vs History
58
vs Industry
19
Median 3Y
23.4
Median 5Y
29.7
Industry
20.5
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
92
vs Industry
46
Median 3Y
2
Median 5Y
2.1
Industry
2.2
More Details
3.4
EV/S
EV/S
Enterprise Value to Sales
3.4
vs History
92
vs Industry
32
Median 3Y
4.1
Median 5Y
4.3
Industry
2.4
Forward
3.3
More Details
4.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.7
vs History
92
vs Industry
42
Median 3Y
5.8
Median 5Y
6
Industry
5
More Details
10.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.2
vs History
93
vs Industry
31
Median 3Y
13.5
Median 5Y
14.2
Industry
12.6
Forward
9.2
More Details
16.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.6
vs History
93
vs Industry
25
Median 3Y
24
Median 5Y
25.5
Industry
17.1
Forward
11.7
More Details
16.3
EV/OCF
EV/OCF
Enterprise Value to OCF
16.3
vs History
92
vs Industry
23
Median 3Y
19.9
Median 5Y
21.5
Industry
14.1
More Details
26.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
26.3
vs History
92
vs Industry
14
Median 3Y
31.8
Median 5Y
35.5
Industry
17.7
More Details
1.2
EV/IC
EV/IC
Enterprise Value to IC
1.2
vs History
90
vs Industry
51
Median 3Y
1.4
Median 5Y
1.4
Industry
1.9
More Details

Multiples Across Competitors

ZBH Competitors Multiples
Zimmer Biomet Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Zimmer Biomet Holdings Inc
NYSE:ZBH
21.6B USD 2.8 20 10.2 16.6
US
Abbott Laboratories
NYSE:ABT
204.7B USD 5 35.5 20.7 30.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.7B USD 23 80.6 68.7 85.3
US
Stryker Corp
NYSE:SYK
139.9B USD 6.4 39 25.3 30.7
US
Boston Scientific Corp
NYSE:BSX
124.8B USD 7.8 69.6 32 45.8
IE
Medtronic PLC
NYSE:MDT
114.5B USD 3.5 29.2 15.2 21.7
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD 3.4 47.9 15.4 27.3
DE
Siemens Healthineers AG
XETRA:SHL
53.6B EUR 2.4 28.8 16.6 24.2
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
338.5B CNY 9.2 26.7 23.5 23.5
US
Edwards Lifesciences Corp
NYSE:EW
40B USD 7.1 9.6 22.2 24.3
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.7B USD 2 23.7 14.7 18.1

See Also

Summary
ZBH intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZBH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZBH stock valuation using valuation multiples.
Wall Street Estimates
ZBH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZBH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 194,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.